P2.12-16 Significant Tumor Regression and Toxicity With Nivolumab Plus Ipilimumab in Small Cell Lung Cancer Patients Following Radiation
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1392
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV